PolarityTE Stock Price

-0.0267 (-2.95%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
PolarityTE Inc PTE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0267 -2.95% 0.876899 14:20:09
Open Price Low Price High Price Close Price Prev Close
0.90 0.851 0.91 0.9036
Bid Price Ask Price Spread News
0.87 0.8769 0.0069 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,466 1,629,922 $ 0.8694766 $ 1,417,179 9,640,694 0.553 - 2.47
Last Trade Time Type Quantity Stock Price Currency
14:20:09 100 $ 0.876899 USD

PolarityTE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 58.58M 66.80M 57.64M $ 5.65M $ - -3.73 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

PolarityTE News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.001.030.8510.95307941,393,016-0.1231-12.31%
1 Month1.281.340.8511.102,492,294-0.4031-31.49%
3 Months1.081.990.8511.315,725,284-0.2031-18.81%
6 Months1.081.990.5531.215,954,938-0.2031-18.81%
1 Year1.102.470.5531.243,378,315-0.2231-20.28%
3 Years17.1523.060.5532.141,546,441-16.27-94.89%
5 Years17.1523.060.5532.141,546,441-16.27-94.89%

PolarityTE Description

PolarityTE Inc is a commercial-stage biotechnology and regenerative biomaterials company. Its focused on transforming the lives of patients by discovering, designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement or regeneration of skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.